{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:49:33Z","timestamp":1793245773330,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2314-B-182 -044 -MY2"],"award-info":[{"award-number":["107-2314-B-182 -044 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jmii.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T11:16:30Z","timestamp":1602933390000},"page":"557-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children"],"prefix":"10.1016","volume":"54","author":[{"given":"Ti-An","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ku","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Che","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-8760","authenticated-orcid":false,"given":"Hong-Ren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2020.10.002_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jmii.2014.08.003","article-title":"Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: a nationwide surveillance","volume":"48","author":"Ma","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.10.002_bib2","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/INF.0b013e31826eb5a7","article-title":"Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan","volume":"31","author":"Chen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2020.10.002_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ppul.22706","article-title":"Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan","volume":"48","author":"Wu","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jmii.2020.10.002_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2020.10.002_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","article-title":"Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children","volume":"29","author":"Wang","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2020.10.002_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmii.2020.10.002_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10156-010-0043-Y","article-title":"A retrospective study of the patients with positive ImmunoCard Mycoplasma test on an outpatient clinic basis","volume":"16","author":"Ishii","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00471-16","article-title":"Role of serum Mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of Mycoplasma pneumoniae-related pneumonia in school-age children and adolescents","volume":"24","author":"Lee","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jmii.2020.10.002_bib9","author":"Kohno"},{"key":"10.1016\/j.jmii.2020.10.002_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pedneo.2017.12.008","article-title":"Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children","volume":"59","author":"Liu","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jmii.2020.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa062","article-title":"Circulating antibody-secreting cell response during Mycoplasma pneumoniae childhood pneumonia","author":"Meyer Sauteur","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2020.10.002_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jiac.2016.02.005","article-title":"Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection","volume":"22","author":"Miyashita","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jiac.2015.02.007","article-title":"Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: comparison with real-time PCR","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib14","first-page":"77","article-title":"Evaluation of \"ImunoAce\u00ae Mycoplasma\", a kit for rapid diagnosis of Mycoplasma pneumoniae infection","volume":"73","author":"Takasaki","year":"2016","journal-title":"Jpn J Med Pharm Sci"},{"key":"10.1016\/j.jmii.2020.10.002_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/prcm.prcm_30_17","article-title":"Role of biocard Mycoplasma immunoglobulin M rapid test in the diagnosis of Mycoplasma pneumoniae infection","volume":"2","author":"Liu","year":"2018","journal-title":"Pediatr Respirol Crit Care Med"},{"key":"10.1016\/j.jmii.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fmicb.2016.00448","article-title":"Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics","volume":"7","author":"Loens","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2020.10.002_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3345\/kjp.2018.07367","article-title":"Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children","volume":"62","author":"Yang","year":"2019","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.jmii.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/AAC.00582-08","article-title":"Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis","volume":"52","author":"Wolff","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2019.12.008","article-title":"Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan","author":"Lu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"Morozumi","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.3346\/jkms.2018.33.e268","article-title":"Therapeutic efficacy and safety of prolonged macrolide, corticosteroid, doxycycline, and levofloxacin against macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children","volume":"33","author":"Ha","year":"2018","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.jmii.2020.10.002_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006454-199810000-00004","article-title":"Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children","volume":"17","author":"Harris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2020.10.002_bib26","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in\u00a0vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib28","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib29","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2020.10.002_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","article-title":"Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae","volume":"7","author":"Yamazaki","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2020.10.002_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jmii.2020.10.002_bib32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","article-title":"No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever","volume":"166","author":"Todd","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jmii.2020.10.002_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/crj.12379","article-title":"Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance","volume":"11","author":"Cao","year":"2017","journal-title":"Clin Res J"},{"key":"10.1016\/j.jmii.2020.10.002_bib34","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/INF.0b013e3181fe353d","article-title":"Ciprofloxacin use in neonates: a systematic review of the literature","volume":"30","author":"Kaguelidou","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2020.10.002_bib35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children","volume":"60","author":"Lu","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.jmii.2020.10.002_bib36","doi-asserted-by":"crossref","first-page":"37037","DOI":"10.1038\/srep37037","article-title":"Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2020.10.002_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","article-title":"Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level","volume":"20","author":"Inamura","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jmii.2020.10.002_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jiac.2014.10.008","article-title":"Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib40","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zhang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jmii.2020.10.002_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","article-title":"Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Shan","year":"2017","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jmii.2020.10.002_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jmii.2020.10.002_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2020.10.002_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cytogfr.2004.01.001","article-title":"Cytokines in Mycoplasma pneumoniae infections","volume":"15","author":"Yang","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jmii.2020.10.002_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ppul.10346","article-title":"New concepts of Mycoplasma pneumoniae infections in children","volume":"36","author":"Waites","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jmii.2020.10.002_bib46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/17460913.3.6.635","article-title":"New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections","volume":"3","author":"Waites","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jmii.2020.10.002_bib47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10156-011-0265-7","article-title":"Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia","volume":"17","author":"Oishi","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2020.10.002_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0000000000002529","article-title":"Meta-analysis of the clinical efficacy and safety of high- and low-dose methylprednisolone in the treatment of children with severe Mycoplasma pneumoniae pneumonia","volume":"39","author":"Sun","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2020.10.002_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jmii.2020.10.002_bib50","doi-asserted-by":"crossref","first-page":"39929","DOI":"10.1038\/srep39929","article-title":"The clinical characteristics of corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children","volume":"6","author":"Yan","year":"2016","journal-title":"Sci Rep"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220302474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:26:11Z","timestamp":1761657971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118220302474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1684118220302474"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2020.10.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}